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Genotype analysis is becoming more and more useful in clinical practice, since
specific mutations in tumors often correlate with prognosis and/or therapeutic
response. Unfortunately, current molecular analytical techniques often require
time-consuming and costly steps of analysis, thus making their routine clinical use
difficult.Moreover, one of themost difficult problems arising during tumor research
is that of their cell heterogeneity, which depends on their clear molecular
heterogeneity. SSCP analysis discriminates by means of aberrant electrophoresis
migration bands, mutated alleles which may represent as little as 15–20% of their
total number. Nevertheless, in order to identify by sequencing the type of alteration
revealed by this technique, only the mutated allele must be isolated. The advent of
laser microdissection is a procedure which easily solves these problems of
accuracy, costs, and time. The aims of this study were to perfect the system of laser
pressure catapulting (LPC) laser microdissection for the assessment of the
mutational status of p53 and k-ras genes in a consecutive series of 67 patients
with colorectal carcinomas (CRC), in order to compare this technique with that
involving hand-dissection and to demonstrate that since the LPC system guarantees
more accurate biomolecular analyses, it should become part of clinical routine in
this field. The LPC-system was perfected with the use of mineral oil and the LPC-
membrane. To compare the techniques of hand- and LPC-microdissection,
alcohol-fixed, paraffin-embedded tissue from 67 cases of CRC were both hand-
and laser-microdissected. In either case, dissected sampleswere analyzed by SSCP/
sequencing and direct sequencing for k-ras and p53 gene mutations. LPC-
microdissection made it possible to pick up mutations by direct sequencing or
SSCP/sequencing, whereas hand-microdissection mutations were identified only
by means of SSCP followed by sequencing; direct sequencing did not reveal any
mutation. In the 67 patients examined by either method, 36% (24/67) showed p53
mutations, 32 of which identified. Seventy-eight percent (25/32) were found in the
conserved areas of the gene, while 12% (4/32) were in the L2 loop, 50% (16/32)
were in the L3 loop, and12% (4/32) in the LSHmotif of the protein.Moreover, of the
67 cases examined, 40% (27/67) showed mutations in k-ras, with a total of 29
mutations identified. Of these, 14 (48%) were found in codon 12 and 15 (52%) in
codon 13. The modifications which we brought to the LPC system led to a vast
improvement of the technique, making it an ideal substitution for hand-
microdissection and guaranteeing a considerable number of advantages regarding
facility, accuracy, time, and cost. Furthermore, the data obtained from the
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mutational analyses performed confirm that the LPC system is more efficient and
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One of the problems involved in the understanding of
tumor progression is how to integrate the information
obtained in molecular analysis with the morphological
and structural results of histological examinations. The
number of tumor cells may often represent less than 50%
of the total tumor tissue cell population, which means
that normal molecular techniques do not always offer
analytical accuracy and may not correspond with the
histological results.
The more homogeneous the sample examined is, the
more accurate the molecular analysis will be. In the
analysis of mRNA or protein expression, it is absolutely
essential to start off with homogeneous material; in fact,
an examination performed on different, mixed cell
populations with potentially different expression values
of any particular gene, would give a result presenting
only the arithmetic mean of the real values of each single
cell type, and the data obtained would have very
little significance (Paweletz et al., 2001). Furthermore,
genomic analysis of homogeneous samples might
require more detailed information about a tissue’s
specificity for a particular genetic alteration. Different
mutational patterns might be present in the endothelial
tissue and in the adjacent fibroblasts, and the neighbor-
ing glandular epithelium of colorectal carcinoma (CRC),
at various stages of differentiation, might present a
different mutational status in specific genes (Kinzler
and Vogelstein, 2002).
Moreover, the molecular profile may be of great help in
refining diagnostic and prognostic assessment. The
mutational status of a small group of selected genes
may, in fact, be useful in determining tumor relatedness
and the profile of certain proteins involved in therapeu-
tic response may help in the clinical definition of
morphological parameters of prognosis (Sirivatanauk-
sorn et al., 1999). Unfortunately, the molecular screen-
ing assays used up till now involve time-consuming and
costly steps of analysis, so that their routine clinical use
is impractical.
For all the above reasons, in the last few years there
have been several attempts to devise a rapid technique
which might make it possible to obtain information
regarding genes and/or proteins on a fairly large amount
of good quality, extremely homogeneous sample mate-
rial (Ellsworth et al., 2003; Judex et al., 2003). At the
present time, laser microdissection would seem to be the
most rapid and efficient system for the selection of cells
from complex normal and diseased tissues (Moskaluk
and Kern, 1997; Dillon et al., 2001; Grant and Jerome,
2002; Greene et al., 2003).
In the light of this, therefore, the aims of this study
were to perfect the laser pressure catapulting (LPC)
laser microdissection system and use it for the assess-
ment of the mutational status of p53 and k-ras genes in a
consecutive series of 67 patients with CRC in order to
compare this method with the hand-microdissection
technique and demonstrate that the use of the LPC
system greatly improves the accuracy of biomolecular
analyses and should therefore be included in routine
clinical practice.
MATERIALS AND METHODS
Patient features. A prospective study was performed
on paired tumor and normal colon tissue samples from a
consecutive series of 67 patients undergoing resective
surgery for primary operable CRC at a single institution
(Department of Oncology, University of Palermo).
Eligibility criteria used were: (a) electively resected
primary CRC, (b) processing of fresh paired normal
mucosa-tumor samples within 30 min after tumor
removal, (c) available DNA from normal and tumor
tissue for biomolecular analyses, and (d) access to
accurate follow-up information. Briefly, the following
exclusion criteria were used: (a) history of previous
neoplasias, (b) patients from families with familial
adenomatous polyposis or hereditary nonpolyposis
CRC with a highly penetrant genetic predisposition to
CRC, (c) synchronous or metachronous CRC, and (d)
chemotherapy or radiation therapy prior to surgery. A
resection of the primary CRC was performed in all cases.
In order to avoid evaluator variability in the patients, all
resection specimens and microscopic slides were meti-
culously examined by two independent pathologists
(RMT and VM) who were not aware of the original
diagnosis and of the results of the molecular analyses.
The complete excision of the primary tumor was proven
by the histopathological examination on 3–5 consecu-
tive 5 mm-thick sections of the proximal and distal
resected margins, respectively. All tumors were histo-
logically confirmed to be CRC. Written informed consent
was obtained from all patients included in this study.
Tissues were fixed in 70% ethyl alcohol and paraffin-
embedded for biomolecular examination.
Tissue preparation
Five-micrometer sections, prepared using a micro-
tome, were mounted on the supporting LPC membrane
already placed on the slide. Subsequent dehydration
was achieved using graded alcohol and xylene treatment
as follows: 95% ethanol for 30 sec (times 2), 100% ethanol
for 30 sec (times 2), and xylene for 5 min (2 times). The
slides were dried under a laminar flow for 10 min and
then stained with hematoxylin and eosin.
Hand-microdissection
The different regions of the tumor were identified and
marked on 5 mm sections and were carefully scraped
with a sterile scalpel from the adjacent 20 mm unstained
paraffin sections.
LPC
LPC was performed using a Zeiss inverted microscope
PALM Laser Micro-Beam System UV laser at 337 nm,
linked to a PC with the required software programs.
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Before performing microdissection, 1 ml of mineral oil
was dripped onto the CRC samples. The areas to be
dissected were selected by means of extremely high-
precision microcuts (the specimens may range from as
little as 1 to 1,000 mm in diameter). After cutting, the
high photonic pressure force of the laser beam was used
to impress a certain amount of kinetic energy onto the
isolated material—the beam hits the tissue from below
and catapults it upwards at high speed for several
millimeters within the appropriately-placed capture
support (the cap of a common Eppendorf-tube). LPC
dissection was performed using a few shots each of
100 mm in diameter. After the catapulting the material
was removed from the cap for analysis.
DNA extraction
Genomic DNA was extracted using the QIAamp
Tissue Kit (Qiagen, Hilden, Germany) with the stan-
dard protocol from primary CRC and normal colorectal
specimens.
Detection of k-ras and p53 gene mutations
by SSCP/sequencing
Mutations within the k-ras and p53 genes were
detected by SSCP analysis following PCR amplification
of the exons 1 for k-ras and of the exons 5–8 for p53
respectively, performed as previously described (Bazan
et al., 2002; Russo et al., 2002). In every instance,
negative (DNA was replaced with water) controls were
amplified by PCR and included in the experiment. In all
PCR assays aerosol-resistant pipette tips were used to
avoid cross-contamination. The quality and the concen-
tration of the amplification products were verified by
1.5% agarose gel electrophoresis and ethidium staining.
One hundred nanogram aliquots of the amplified DNA
fragments, purified and concentrated by filtration
through Microcon 50 columns (Amicon, Beverly, MA)
were denatured and analyzed by SSCP analysis. DNA of
normal colon tissue from each patient was also amplified
and run in parallel with matched tumoral DNA samples
on SSCP gels, to evaluate the occurrence of germ-line
mutations or polymorphisms. Individual ssDNA frag-
ments with shifted mobilities, compared to normal
control, were electroeluted from polyacrylamide gel, as
described previously (Albanese et al., 1997), reamplified
and sequenced. Automated sequencing was performed
using the Big Dye Terminator Cycle Sequencing Kit
(Applied Biosystems, Foster City, CA) and the model
3100 DNA sequencer (Perkin-Elmer, Foster City, CA).
Detection of k-ras and p53 gene mutations
by sequencing
Mutations within the k-ras and p53 genes were
detected by direct sequencing following PCR amplifica-
tion. The same exons of k-ras (exon 1) and of p53 (exons
5–8) were amplified as previously described, and auto-
mated sequencing was performed using the same se-
quencing kit and the same sequencer.
RESULTS
Optimization of the LPC-system
The addition of 1 ml of mineral oil dripped onto 5 mm
sections of mucosa and of CRC mounted on a support-
ing membrane greatly improved visibility (Fig. 1), thus
guaranteeing a clearer discrimination of the different
zones under observation and also facilitating the cutting
and subsequent catapulting procedures (Fig. 2).
Mutation analysis of p53 gene
Mutation analysis of exons 5–8 of the p53 gene was
performed on genomic DNA from primary CRCs of
67 patients by PCR-SSCP/sequencing and by PCR/direct
sequencing. Tumor tissue was obtained by hand- and by
LPC-microdissection. Aberrantly migrating bands were
found in 36% (24/67) of the cases (Fig. 3) with a total of
32 mutations. The presence of abnormal bands was
assessed in at least two independent SSCP analyses.
Sequence analysis of the DNA fragments with altered
electrophoretic mobility made it possible to establish the
exact site and nature of the genetic alteration. The
features of the p53 mutations are summarized in
Table 1. Of the 32 mutations, 32% (10 of 32) were in
exon 5, 6% (2 of 32) in exon 6, 47% (15 of 32) in exon 7, and
16% (5 of 32) in exon 8. Furthermore, 25% (8/32) of the
mutations were frameshift, of which 7 were deletions
and one was insertion; l.75% (24/32) were single-
nucleotide substitutions distributed as follows: 23 mis-
sense and 1 silent mutations in codon 249 previously
identified as the site of polymorphism. Moreover, tran-
sitions were of 56% (18/32) and transversions of 19%
(6/32). No germ-line mutations were found, indicating
that in every case the change was somatic. Twenty-five
mutations (78%) were in the conserved areas, 2 of which
in area II, 3 in area III, 15 in area IV, and 5 in area V. In
addition, by taking into account the specific functional
and structural domains of p53 affected by the mutations,
the cases were also classified as follows: 12% (4/32) in the
L2 loop, 50% (16/32) in the L3 loop, 12% (4/32) in the LSH
motif of the protein, and 26% (8/32) with mutations
outside L2, L3, and LSH.
Fig. 1. Typical image of the progress of the oil spreading throughout
normal tissue and throughout tumoral tissue (H&E staining;
magnification: 400). a: Normal human mucosa without oil; (b) note
the good quality of the image after the oil has spread in the tissue; (c)
tumoral tissue without oil; (d) note the good quality of the image after
the oil has spread in the tissue.
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Hand-microdissection did not make it possible to pick
up any mutation, which could only be identified by
means of subsequent SSCP and sequencing. The use of
the LPC microdissection technique revealed mutations
with both the SSCP and PCR/direct sequencing techni-
ques (Fig. 4).
Mutation analysis of the k-ras gene
Mutation analysis of exon 1 of the k-ras gene was
performed on genomic DNA from primary CRCs of 67
patients by PCR-SSCP/sequencing and by PCR/direct
sequencing. Tumor tissue was obtained by hand- and by
LPC-microdissection. Aberrantly migrating bands were
found in 40% (27/67) of the cases with a total of 29
mutations. The presence of abnormal was assessed in at
least two independent SSCP analyses. Sequence analy-
sis of the DNA fragments with altered electrophoretic
mobility made it possible to establish the exact site and
nature of the genetic alteration in all the tumor samples.
The features of the k-ras mutations are summarized in
Table 2. Of the 29 mutations, 14 (48%) were found in
codon 12, and 15 (52%) in codon 13; 25/27 tumors
presented single mutations, 2/27 a mutation in codon 12
and one in codon 13. No mutations were detected at any
other site of the first exon. The most frequent mutation
in codon 12 was GGT to GAT (Gly!Asp), which was
observed in 5/14 mutations (36%). The other mutations
observed in the same codon resulted in replacement of
glycine with valine (GGT to GTT, 4/14 cases, 29%), or
cysteine (GGT to TGT, 3/14 cases 21%), or serine (GGT to
AGT, 2/14 cases 14%). The only mutation in codon 13
was GGC to GAC (Gly!Asp) which was detected in all
cases (100%). Overall, transitions (81%, 22 of 27) were
far more frequent than transversions (19%). No germ-
line mutations were found, indicating that in every case
the change was somatic. Once again in this case hand-
microdissection did not permit direct sequencing to pick
up any mutations, which were only identified by means
of SSCP followed by sequencing, whereas LPC micro-
dissection made it possible to find mutations with both
techniques (SSCP or PCR/direct sequencing).
DISCUSSION
An extremely important advantage of the LPC system
is that it cuts out all contact between the operator and
the prepared sample, which means an enormous reduc-
tion in human error and eliminates the risk of damage
being caused by possible contamination or infection
(Bernsen et al., 1998; Schindler, 1998; Hunt et al., 2003).
One of the basic problems of the LPC system is
ensuring clear visibility of the prepared specimen. Since
laser microdissection does not permit the use of a cover-
slide, which would prevent the selected cells from rising
up towards the capture cap, in most cases the specimen
appears dark and opaque. This fact is due to non-specific
scattering of light, that is, to the lack of refractive index
matching between the desiccated tissue and the inter-
stitial air. This means that it is more or less impossible
to identify particular cytological features. In order to
improve visibility in the LPC system, a membrane can
be placed on the dissected tissue, thus mimicking the
presence of a cover-slide, without, however, blocking the
catapulting procedure, since the membrane can be cut
and transferred into the capture cap together with the
tissue (Nagasawa et al., 2000). Nevertheless, this pro-
cedure, which is intended to improve visibility, has a
serious disadvantage; once the selected specimen has
been cut, air may get between the membrane and the
tissue, once again reducing visibility of the adjacent
areas which are thus no longer suitable for the
subsequent microdissection. Moreover, the procedure
followed for mounting the membrane must be performed
extremely carefully in order not to destroy the tissue and
to avoid the formation of air bubbles.
Since the mineral oil permits a specific scattering of
light, we also dripped a few drops onto the specimen
itself in order to improve visibility even more. After a
minute or two, the oil spreads throughout the whole
Fig. 2. Typical image of the laser pressure catapulting (LPC) process involving an epithelial gland of
tissue placed on a slide together with a membrane after the addition of 1 ml of mineral oil. a: Improvement
of tissue visibility after the addition of oil on the slide with the membrane; (b–c) cutting and catapulting
of the gland; (c) catapulted gland on the Eppendorf cap.
Fig. 3. SSCP analysis of exon 5 of p53 gene in colon mucosa (M) and
colorectal carcinomas (CRC) (T) from 67 samples. The sample
extracted by hand microdissection (H.M.) can be seen in lanes 1 and
2, while lanes 3 and 4 show the samples extracted by LPC
microdissection (L.M.). Lane 5 shows a control sample.
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specimen, when it is then possible to obtain a perfect
vision of the morphology of the tissue and to make an
accurate choice of the zone to be microdissected (Fig. 1).
In some cases, it may happen that the oil used in this way
stops the material isolated by the laser ray from
reaching the cap even though it has been detached from
the surface of the slide: in this case, the tissue appears
too soft, and the fragments floating about in the oil are
difficult to hit with the tiny catapult, requiring a large
number of shots before all of them are captured. These
difficulties regarding transfer problems were solved by
mounting the tissue on the supporting LPC-membrane,
thus transferring even a wide selected zone with a single
shot, in spite of the presence of the mineral oil (Fig. 1).
One of the most difficult problems arising during
tumor research is that of their cell heterogeneity, which
Fig. 4. Comparison between mutational analysis of genes k-ras and p53 by means of hand-micro-
dissection and with the use of the LPC system. With the former technique, direct sequencing showed
no mutations (a), which were picked up only by means of sequencing following the SSCP technique (b);
LPC-microdissection made it possible to identifiy mutations with both techniques (direct sequencing or
SSCP/sequencing) (c–d).
TABLE 1. Distribution of 32 mutations identified in p53 gene exons 5–8 in 67 CRCs
Sample
Mutated
exon
Mutated
codon
Nucleotide
change
Aminoacid
change
Type
mutation CD Zn-BD
13 K 8 273 cgt! cat arg!his Missense Y LSH
26 K 7 238þ tgt! tat cys! tyr Missense Y L3
249 agg! ag- arg! Frameshift Y L3
27 K 5 155 acc!ac- thr! Frameshift N
28 K 5 174 agg! aag arg! lys Missense Y L2
36 K 5 158 cgc! cac arg!his Missense N
70 K 7 244þ ggc!agc gly! ser Missense Y L3
249 agg! ag- arg! Frameshift Y L3
77 K 8 272 gtg! atg val!met Missense Y
114 K 5þ 141 tgc! cgc cys! arg Missense Y
6 204 gag! tag glu!STOP Nonsense N
125 K 7 248 cgg! tgg arg! trp Missense Y L3
147 K 8 282 cgg! tgg arg! trp Missense Y LSH
195 K 7 244þ ggc!agc gly! ser Missense Y L3
249 agg! ag- arg! Frameshift Y L3
338 K 7 244 ggc!agc gly! ser Missense Y L3
351 K 5 152 ccc! cccc pro! Frameshift N
398 K 6þ 220 tat! tgt tyr! cys Missense N L3
7 244þ ggc!agc gly! ser Missense Y L3
249 agg! ag- arg! frameshif Y L3
406 K 5 174 agg! aag arg! lys Missense Y L2
421 K 5 177 ccc! cc- pro! Frameshift Y L2
452 K 7 248 cgg! tgg arg! trp Missense Y L3
463 K 8 273 cgt! cat arg!his Missense Y LSH
499 K 8 278 cct! tct pro! ser Missense Y LSH
627 K 5 151 ccc! acc pro! thr Missense N
678 K 7 244þ ggc!gcc gly! ala Missense Y L3
249 agg! cgg arg! arg Silent Y L3
706 K 5 163 tac! ttc tyr!phe Missense N L2
757 K 5 141 tgc! tcc cys! ser Missense Y
817 K 7 244þ ggc!agc gly! ser Missense Y L3
249 agg! ag- arg! Frameshift Y L3
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depends on their clear molecular heterogeneity (Moyret
et al., 1994; Keohavong et al., 2004). The multi-step
model has revealed that a neoplasia develops pro-
gressively as a result of the accumulation of various
alterations of at least five or six different genes impli-
cated in cell cycle control, differentiation and apoptosis
(programmed cell death) (Kinzler and Vogelstein, 2002).
This fact not only explains why the tumor mass often
presents with cell sub-clones which may be extremely
different one from the other, both with regard to pheno-
type and genotype, but is also why the routine clinical
use of biomolecular analysis is so enormously compli-
cated. Furthermore, in order to be really accurate,
tumor genotyping requires a series of costly and time-
consuming steps.
Before the technique of laser microdissection was
developed, tumor cells would be isolated onto a slide by
means of manual microdissection; this meant that the
selected zone often contained a significant proportion of
other cell types which weaken the tumor-specific
signals. Mutational screening requires clear discrimi-
nation between tumor-correlated genic alterations and
wild-type genotypes. Unfortunately, mutational analy-
sis performed with the use of direct sequencing permit-
ting PCR is impeded by the presence of wild-type
phenotype, and therefore genotype, cells. Thus through-
out the years, several other, alternative mutational
assays which by-pass this problem have been preferred;
of these, the one with the highest sensitivity and spe-
cificity has proved to be the SSCP (Hongyo et al., 1993;
Moyret et al., 1994; Soong and Iacopetta, 1997; Kutach
et al., 1999; Keohavong et al., 2004). This analysis per-
mits PCR and, in fact, discriminates by means of aber-
rant electrophoresis migration bands, mutated alleles
which may represent as little as 15–20% of all the
alleles. Nevertheless, in order to identify by sequencing
the type of alteration revealed by this technique, only
the mutated allele must be isolated, which means that
the band with altered electrophoretic migration must be
cut, and its DNA eluted, purified, and reamplified, in
order to obtain a sufficient quantity for sequencing. All
of this obviously takes a great deal of time and money
and may also lead to loss of the sample.
The advent of laser microdissection is a procedure
which easily solves these problems of accuracy, costs,
and time.
In a group of 67 cases of CRC, we compared the results
obtained with the technique of hand-microdissection for
the mutational analysis of k-ras and p53 genes with
those obtained with the use of the LPC system. We
analyzed the DNA obtained with both techniques, one
part by means of direct sequencing and one part with the
SSCP analysis, followed by sequencing performed in
various preparatory steps. Of the 67 cases analyzed, 40
proved to be wild-type when mutational analysis was
performed by sequencing or by SSCP/sequencing and
preceded by hand microdissection or by LPC-microdis-
section.
Of the 67 cases examined, 36% (24/67) showed
mutations in p53 and 40% (27/67) in k-ras (Fig. 4).
Following hand-microdissection, the mutations were
identified only by means of SSCP/sequencing (Fig. 4b);
direct sequencing did not show up any mutations
(Fig. 4a). On the contrary, LPC-microdissection made it
possible to identify the mutations with either technique
(direct sequencing or SSCP/sequencing) (Fig. 3c,d),
confirming the validity of the LPC system to reduce
the time required for mutational analysis. As Figure 3,
in fact, shows, when the specimen is hand-microdis-
sected, there is a strong likelihood of scraping normal
cells, that is, wild-type alleles, together with the tumor
cells, and therefore mutated alleles, which means that it
is impossible to establish their molecular type by means
of simple direct sequencing. The selection of tumoral
cells by means of LPC, however, results in a number of
tumoral versus wild-type alleles which it is possible to
identify by means of direct sequencing.
CONCLUSIONS
Laser microdissection systems have now taken the
place of needle manipulation for scraping off cells from
the sample, leading to great improvement in the
technique; the LPC-system is particularly quick and
efficient, and its use makes it possible to isolate a smaller
number of homogeneous cells; this method is less
dependent on the operator’s skill and not as subject
to possible contaminations as other techniques, since
it entirely eliminates contact between the operator and
the prepared sample (Schutze et al., 1998). LPC-
microdissection makes it possible to perform extremely
high-precision microcuts, thus improving the quality of
the material obtained and guaranteeing a more accurate
biomolecular characterization of samples. Moreover, the
use of the LPC-system leads to a considerable reduction
in the time and costs required for biomolecular profile
analysis.
This technique, used together with other modern
methods of biomolecular analysis, guarantees a more
efficient and accurate genotyping of tumor samples, and
improves the stratification of patients with CRC, thus
permitting a more personalized therapeutic approach. If
in the future our results are confirmed by further clinical
TABLE 2. Distribution of 29 mutations identified in k-ras gene exon 1 in 67 CRCs
Mutated codon Type of mutation
Mutated sequence
(aminoacid)
No. of
mutations (%)
12 Transitions
(1st pos.) GGT-AGT (Gly-Ser) 2 (14)
(2nd pos.) GGT-GAT (Gly-Asp) 5 (36)
Transversions
(1st pos.) GGT-TGT (Gly-Cys) 3 (21)
(2nd pos.) GGT-GTT (Gly-Val) 4 (29)
Total mutations 14
13 Transitions (2nd pos.) GGC-GAC (Gly-Asp) 15 (100)
Total mutations 15
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studies involving a larger number of cases, the LPC
technique could be used in future routine clinical
procedures.
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